Actively Recruiting

Phase Not Applicable
Age: 65Years +
MALE
ID07435168

CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

Led by Rigshospitalet, Denmark · Updated on 2026-02-27

300

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting a study to find out how common Cardiac Amyloidosis (CA) is in men aged 65 and older who have chest pain but no signs of coronary artery disease (CAD). This observational, prospective study includes patients who already had a CT coronary angiogram or Rb-PET scan to exclude CAD before joining. Participants will undergo several tests such as blood tests, urine samples, ECG, echocardiography, and bone scintigraphy to check for signs of CA. If needed, an endomyocardial biopsy may be performed to gather more information. This is not a drug trial but an assessment through examinations. During the study, researchers will carefully monitor participants using these tests to measure how often CA occurs in this group of men. The main outcome is to determine the prevalence of ATTR-CA within four weeks. The study is sponsored by Rigshospitalet, Denmark, and participation involves regular evaluations without treatment interventions.

CONDITIONS

Brief Title

CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

Who Can Participate

Age: 65Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male gender
  • Age 65 years or older
  • Experiencing chest pain
  • No signs of coronary artery disease based on Rb-PET and/or CT coronary arteriogram
Not Eligible

You will not qualify if you...

  • Previous history of amyloidosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - Up to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) including clinical examination, blood samples, echo, and bone scintigraphy

Surveillance

Duration - Up to 4 weeks

Participants are observed to identify the presence of cardiac amyloidosis related to chest pain.

No additional visits beyond screening

Trial Site Locations

Total: 1 location

1

Rigshospitalet

Copenhagen, Denmark, 2100

Actively Recruiting

Loading map...

Research Team

N

Navid Noory, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Similar Trials

[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus ...

Cardiac Amyloidosis

Actively Recruiting

1 location

A Multi-center Registry for Clinical Information and 99mTc-p...

Heart Failure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here